Please use this identifier to cite or link to this item: doi:10.22028/D291-27544
Title: Psychoactive substances as substrates or inhibitors of enzymes in drug metabolism and transport
Author(s): Wagmann, Lea
Language: English
Year of Publication: 2018
DDC notations: 500 Science
Publikation type: Dissertation
Abstract: In contrast to therapeutic drugs, drugs of abuse (DOA) are marketed without (pre)clinical studies. In order to expand the knowledge surrounding toxicokinetics of DOA, the affinity and/or inhibition potential of selected DOA towards human metabolic enzymes such as monooxygenases or monoamine oxidases (MAO) and an efflux transporter, the breast cancer resistance protein (BCRP), was investigated using mass spectrometry techniques. FMO3 was identified as main enzyme involved in the N-oxygenation of N,N-diallyltryptamine and methamphetamine. Furthermore, a broad range of alpha-methyltryptamine-derived new psychoactive substances but also phenethylamines of the 2C-series were identified as MAO inhibitors. Finally, the BCRP ATPase was shown to be potently stimulated or inhibited by 3,4-BDB or WIN 55,212-2, respectively, comparable to model substrates or inhibitors.
Link to this record: urn:nbn:de:bsz:291-scidok-ds-275444
Advisor: Maurer, Hans Hilarius
Date of oral examination: 16-Nov-2018
Date of registration: 27-Nov-2018
Faculty: NT - Naturwissenschaftlich- Technische Fakultät
Department: NT - Pharmazie
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
Dissertation_Wagmann_Pflichtexemplar.pdf9,27 MBAdobe PDFView/Open

Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.